Dulaglutide, 923950-08-7

Aha ahaulaglutide - ngwọta na PBS / dulaglutide

CAS Nọmba: 923950-08-7

Ụlọ ọrụ Nọmba: GT-F002

Usoro: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile- Ala-Trp-Leu-Val-Lys-Gly-Gl y-Gly-OH

Usoro ihe omimi: C149H221N37O49

Ibu ibu: 3314.62

Dulaglutide CAS NO.923950-08-7.jpg

Ngosipụta nka na ụzụ:

Ọdịdị ọcha ntụ ntụ
Ịdị ọcha (HPLC) bụ ≥95.0%

Otu heterozygosity erughị 2.0%

Ọdịnaya acetic acid sitere na 5.0% ruo 12.0%

Ọdịnaya mmiri dị ≤10.0%

Ọdịnaya peptide bụ ≥80.0%

Nbukota na mbupu:

Okpomọkụ dị ala, nkwakọ ngwaahịa agụụ, ziri ezi ruo milligram mgbe achọrọ ya.

Nkọwa ngwaahịa:

Durraglutide bụ GLP-1R agonist ọhụrụ na-eme ogologo oge, nke sitere na njikọta nke abụọ DPP-4 inhibitory GLP-1 analogues na ụmụ mmadụ immunoglobulin arọ IgG4-Fc.Ọrụ ya yiri nke GLP-1 endogenous na ngosipụta ụlọ ọgwụ, yana ọkara ndụ nke ụbọchị 5, ma nwee ike igbu oge mkpochapụ akụrụ nke ọma.FDA kwadoro dulaglutide maka injection subcutaneous na Septemba 2014. European Commission kwadoro dulaglutide maka injection subcutaneous na Europe na December 2014.

Nchekwa: Ghichaa na -20 ℃ ma chekwaa ya na ìhè

Nkọwa: Maka ebumnuche nyocha naanị, ọ bụghị maka ihe mmadụ